Verona Pharma plc

This stock has a reasonable momentum. Verona Pharma plc is not a good value stock. Verona Pharma plc is not a good growth stock. Verona Pharma plc is not very popular among insiders. Verona Pharma plc is a mediocre stock to choose.

Verona Pharma Plc operates as a clinical-stage biopharmaceutical company focused on developing and c...

News

Verona Pharma: A Post FDA Approval Analysis

SeekingAlpha Verona Pharma: A Post FDA Approval Analysis...\n more…

Candriam S.C.A. Takes $11.18 Million Position in Verona Pharma plc (NASDAQ:VRNA)

Ticker Report Candriam S.C.A. bought a new stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought...\n more…

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

Globe Newswire One oral presentation and three posters support Ohtuvayre (ensifentrine), as a first-in-class, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE...\n more…

Verona Pharma plc (NASDAQ:VRNA) Short Interest Update

Ticker Report Verona Pharma plc (NASDAQ:VRNA - Get Free Report) saw a significant growth in short interest in August. As of August 15th, there was short interest totalling 10,700,000 shares, a growth of 21.0% from...\n more…

Verona Pharma management to meet virtually with Piper Sandler

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…